BOT price action, page-741

The recent appointments of Mr Vince Ippolitto and Dr Stewart Washer should add great wealth to my portfolio. Are they here to sell the farm? Or, should that be the pharm?

Taken from the relative announcements:

Dr Washer
Is an experienced executive with more than 20 years of Board and senior executive medical technology, biotechnology and agrifood companies. He has an established track record and has overseen several acquisitions and strategic partnerships in the pharmaceutical and cannabinoid medicine sectors, with some of the world’s leading companies.

As for Vince
As Executive Vice President and Chief Commercial Officer, Vince has played a leading role in two large dermatology transactions with a combined valuation of US$7.8bn, including the recent sale of dermatology Anacor to Pfizer for US$5.2bn. Mr Ippolito has more than 30 years of experience in the pharmaceuticals industry, including more over 20 years experience in dermatology. He most recently served as President and Chief Operating Officer of Dermavant Sciences, a specialty biopharmaceutical company that is commercialising products which treat inflammatory skin diseases and medical dermatologic conditions which recently completed a US$330m transaction with GSK. Mr Ippolito also sits on the Board of Suneva Medical, a privately held regenerative aesthetics company.Prior to his role at Dermavant Sciences, Mr Ippolito served as the Chief Commercial Officer and Executive Vice President of Anacor Pharmaceuticals, a dermatology-based biopharmaceutical company. During his time at Anacor he was responsible for building the marketing and sales functions, and developing the company’s product portfolio, as well as playing a key role in the US$5.2bn sale to Pfizer.

Seatbelts required.
All IMO of course